282 related articles for article (PubMed ID: 33037405)
1. MicroRNAs are involved in the development and progression of gastric cancer.
Liu X; Ma R; Yi B; Riker AI; Xi Y
Acta Pharmacol Sin; 2021 Jul; 42(7):1018-1026. PubMed ID: 33037405
[TBL] [Abstract][Full Text] [Related]
2. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
[TBL] [Abstract][Full Text] [Related]
5. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
6. microRNA-95 knockdown inhibits epithelial-mesenchymal transition and cancer stem cell phenotype in gastric cancer cells through MAPK pathway by upregulating DUSP5.
Du M; Zhuang Y; Tan P; Yu Z; Zhang X; Wang A
J Cell Physiol; 2020 Feb; 235(2):944-956. PubMed ID: 31309567
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer.
Song Y; Li Q; Liao S; Zhong K; Jin Y; Zeng T
Virology; 2020 Sep; 548():6-16. PubMed ID: 32530809
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNAs in gastric cancer.
Ishiguro H; Kimura M; Takeyama H
World J Gastroenterol; 2014 May; 20(19):5694-9. PubMed ID: 24914330
[TBL] [Abstract][Full Text] [Related]
9. Roles of microRNAs in cancer associated fibroblasts of gastric cancer.
Yan Y; Wang R; Guan W; Qiao M; Wang L
Pathol Res Pract; 2017 Jul; 213(7):730-736. PubMed ID: 28554761
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-501-3p targeting TM4SF1 facilitates tumor-related behaviors of gastric cancer cells via EMT signaling pathway.
Wei Y; Yin L; Xie X; Wu Z; Zhang J; Gao Y; Tang J
Mutat Res; 2022; 825():111802. PubMed ID: 36274500
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
12. miR-492 promotes chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induces stemness in gastric cancer.
Wu S; Xie J; Shi H; Wang ZW
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32065219
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA CircCACTIN Promotes Gastric Cancer Progression by Sponging MiR-331-3p and Regulating TGFBR1 Expression.
Zhang L; Song X; Chen X; Wang Q; Zheng X; Wu C; Jiang J
Int J Biol Sci; 2019; 15(5):1091-1103. PubMed ID: 31182928
[No Abstract] [Full Text] [Related]
14. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis.
Chen Z; Wu J; Huang W; Peng J; Ye J; Yang L; Yuan Y; Chen C; Zhang C; Cai S; He Y; Wu S; Song W
Cell Physiol Biochem; 2018; 47(6):2432-2444. PubMed ID: 29991048
[TBL] [Abstract][Full Text] [Related]
16. miRNAs, Melanoma and Microenvironment: An Intricate Network.
Romano G; Kwong LN
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29112174
[TBL] [Abstract][Full Text] [Related]
17. MiR-92a antagonized the facilitation effect of extracellular matrix protein 1 in GC metastasis through targeting its 3'UTR region.
Liu LQ; Hu L; Hu XB; Xu J; Wu AM; Chen H; Gu PY; Hu SL
Food Chem Toxicol; 2019 Nov; 133():110779. PubMed ID: 31472228
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer.
Wu DM; Hong XW; Wang LL; Cui XF; Lu J; Chen GQ; Zheng YL
Int J Biochem Cell Biol; 2018 Sep; 102():59-70. PubMed ID: 29953965
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.
Chen XB; Li W; Chu AX
J Cell Biochem; 2019 Jan; 120(1):470-480. PubMed ID: 30161272
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-4513 Promotes Gastric Cancer Cell Proliferation and Epithelial-Mesenchymal Transition Through Targeting KAT6B.
Ding H; Shi Y; Liu X; Qiu A
Hum Gene Ther Clin Dev; 2019 Sep; 30(3):142-148. PubMed ID: 31310159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
